R51K (p.Arg51Lys) variant of CDKN2A (Tumor suppressor ARF)

R51K (p.Arg51Lys) in CDKN2A (Tumor suppressor ARF) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Hereditary cancer-predisposing syndrome. The available variant effect predictions contribute to a CATVariant prioritization score of 0.72 / 1. The record also includes published literature and structural context.

R51K (p.Arg51Lys) variant details